Pharmaceutical

Mezzion Secures $20 Million in Strategic Funding to Advance Global Phase 3 Clinical Development of Udenafil for Fontan Patients

SEOUL, South Korea, June 11, 2025 /PRNewswire/ -- Mezzion Pharma Co., Ltd. (Mezzion) announced a major milestone in their clinical…

7 months ago

Axtria Ignite 2025: Defining Leadership in the Agentic AI Era for the Life Sciences Industry

Axtria Ignite 2025 Champions Life Sciences Innovation with a Focus on AI-driven transformations, Patient-Centricity, and Next-Generation TherapiesHonoring Excellence: Ignite Leadership…

7 months ago

Medtech Industry Establishes Foundation for Clinical Trials with Veeva MedTech

More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed…

7 months ago

Novo Nordisk selects Gefion AI Supercomputer to advance drug discovery and healthcare innovation

PARIS, June 11, 2025 /PRNewswire/ -- NVIDIA GTC Paris at VivaTech -- DCAI today announced that Novo Nordisk has become a customer…

7 months ago

Lembas Emerges from Stealth with Breakthrough Discovery in Natural GLP-1 for Weight Management

Following successful validation, the AI-driven bioactive discovery company announces $3.6 mm round to scale next-gen food-as-medicine metabolic health solutions TEL…

7 months ago

Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress

All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR);…

7 months ago

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage…

7 months ago

Lisata Therapeutics to Present at the 2025 BIO International Convention

BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…

7 months ago

Veru to Participate in the Virtual BTIG Obesity Health Forum

MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

7 months ago